Stock OCEA OCEAN BIOMEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Ocean Biomedical, Inc.

Equities

OCEA

US67644C1045

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-07 EDT 		5-day change 1st Jan Change
1.445 USD -0.69% Intraday chart for Ocean Biomedical, Inc. -9.69% +118.94%
05-30 Ocean Biomedical Gets Nasdaq Noncompliance Notice; Shares Down MT
04-15 Ocean Biomedical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024
AQ
Ocean Biomedical Gets Nasdaq Noncompliance Notice; Shares Down
MT
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
AQ
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
AQ
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
AQ
Ocean Biomedical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL
AQ
Ocean Biomedical, Inc. Appoints Amy Griffith as Director
CI
Ocean Biomedical, Inc. Announces CFO Changes
CI
Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting
AQ
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
AQ
North American Morning Briefing : S&P 500 Futures -2-
DJ
North American Morning Briefing : Central Bankers -2-
DJ
North American Morning Briefing : Stocks to -2-
DJ
North American Morning Briefing : Stock Futures Extend Losses as FOMC Minutes Awaited
DJ
North American Morning Briefing : S&P 500 Futures Dip with Fresh Record in Sight
DJ
North American Morning Briefing : Traders Await -2-
DJ
Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody
AQ
Ocean Biomedical Announces Publication of Breast Cancer Research Uncovering New Tumor Suppression Pathway for its Proprietary Anti-Chi3L1 Antibody
CI
Ocean Biomedical Receives Non-Compliance Notice From Nasdaq
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OCEA Stock
  4. News Ocean Biomedical, Inc.